Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
5.60
+0.12 (2.19%)
Jan 30, 2026, 4:00 PM EST - Market closed
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $355.62 million as of January 30, 2026. Its market cap has decreased by -7.90% in one year.
Market Cap
355.62M
Enterprise Value
211.51M
1-Year Change
-7.90%
Ranking
Category
Stock Price
$5.60
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has decreased from $397.73M to $355.62M, a decrease of -10.59%. That is a compound annual growth rate of -2.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 355.62M | 2.75% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aclaris Therapeutics | 380.29M |
| Protara Therapeutics | 379.40M |
| Rocket Pharmaceuticals | 376.61M |
| Enanta Pharmaceuticals | 374.34M |
| Tectonic Therapeutic | 374.14M |
| Zura Bio | 369.33M |
| Autolus Therapeutics | 364.62M |
| Lineage Cell Therapeutics | 358.64M |